Related Experiment Video
Updated: May 22, 2026

Measuring the Motor Aspect of Cancer-Related Fatigue using a Handheld Dynamometer
Published on: February 20, 2020
Handgrip strength and relationship with non-motor symptoms in Parkinson's disease
Daniele Urso1,2, Roberta Barone1, Davide Vilella1
1Center for Neurodegenerative Diseases and the Aging Brain, Department of Clinical Research in Neurology, University of Bari 'Aldo Moro', "Pia Fondazione Cardinale G. Panico", Tricase, Lecce, Italy.
Abstract:
BackgroundMuscle weakness, particularly reduced handgrip strength (HGS), is a prominent clinical feature in Parkinson's disease (PD). While the relationship between motor symptoms and muscle strength has been extensively studied, the connection between HGS and non-motor symptoms (NMS) remains less explored.ObjectiveThis study investigates the relationship between HGS and NMS in PD patients, hypothesizing that higher burden of NMS is associated with a reduced HGS.MethodsFifty consecutive PD patients were enrolled and underwent comprehensive neurological and neuropsychological evaluations, 3T MRI scans, routine laboratory tests, and 123I-Ioflupane SPECT imaging. HGS was measured using a DynEx hand dynamometer, and NMS were assessed using the Non-Motor Symptoms Scale (NMSS). Cognitive function was evaluated with a battery of 18 psychometric tests, and quality of life was assessed using the Parkinson's Disease Questionnaire-8 (PDQ-8).ResultsReduced HGS was observed in the majority of PD patients and was significantly correlated with higher NMSS scores, particularly in mood and cognitive domains. Lower HGS was also linked to poorer quality of life. In linear regression models, NMSS remained a significant predictor of HGS even when controlling for age, sex, and Mini-Mental State Examination scores.Conclusions:Our findings suggest that HGS could serve as a valuable biomarker for non-motor symptoms, including depression and cognitive dysfunction, in PD patients. This study underscores the importance of integrating HGS measurements into clinical practice to identify muscle weakness and cognitive impairment, guiding more targeted interventions to improve patient outcomes.
Related Concept Videos
Parkinson Disease l: Introduction
Alterations in Muscle Tone lll
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease: Overview
Parkinson Disease ll: Pathophysiology
